A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder
- 22 December 2005
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 59 (9) , 829-835
- https://doi.org/10.1016/j.biopsych.2005.09.011
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderBiological Psychiatry, 2005
- Methylphenidate and Dextroamphetamine Abuse in Substance‐Abusing AdolescentsThe American Journal on Addictions, 2004
- Stimulant treatment of adult attention-deficit/hyperactivity disorderPsychiatric Clinics of North America, 2004
- Adult attention-deficit/hyperactivity disorderPsychiatric Clinics of North America, 2004
- Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHDAmerican Journal of Psychiatry, 2003
- Use of Self-Ratings in the Assessment of Symptoms of Attention Deficit Hyperactivity Disorder in AdultsAmerican Journal of Psychiatry, 2000
- Attention Deficit Disorder and Methylphenidate: Group and Single-Subject Analyses of Dose Effects on Attention in Clinic and Classroom SettingsJournal of Clinical Child Psychology, 1987
- Attention Deficit Disorders in AdultsClinical Neuropharmacology, 1985
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959